Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analgesic Efficacy and Safety of Nalbuphine Versus Morphine for Perioperative Tumor Ablation: a Randomized, Control, Multicentre Trial

NCT05073744 is registered in ClinicalTrials.gov with Zhongda Hospital as lead sponsor.

NCT NCT05073744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05073744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analgesic Efficacy and Safety of Nalbuphine Versus Morphine for Perioperative Tumor Ablation: a Randomized, Control, Multicentre Trial
Lead sponsor
Zhongda Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
September 5, 2021
Completion date
August 31, 2023
Enrollment
316 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

ablation, nalbuphine allergy, safety